Clinical Trial Update: Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating Proscavax vaccine in patients with localized prostate cancer compared to active surveillance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Proscavax

Snippet

Sponsor: OncBioMune Pharmaceuticals | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN